跳至主要内容
临床试验/NCT01716858
NCT01716858已完成2 期

Sulforaphane-rich Broccoli Sprout Extract for Schizophrenia

Chiba University1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2012年10月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
10
试验地点
1
主要终点
Positive and Negative Syndrome Scale (PANSS)

研究概览

简要总结

Accumulating evidence suggests a role of oxidative stress in the pathophysiology of schizophrenia. The potent antioxidant sulforaphane (SFN) is an organosulfur compound derived from a glucosinolate precursor found in cruciferous vegetables such as broccoli, Brussels sprouts and cabbage. The protection afforded by SFN is thought to be mediated via activation of the NF-E2-related factor-2 (Nrf2) pathway and subsequent up-regulation of phase II detoxification enzymes and antioxidant proteins, through an enhancer sequence referred to as the electrophilic responsive element or antioxidant responsive element. Recently, we reported that SFN could attenuate behavioral abnormalities in mice after the NMDA receptor antagonist phencyclidine. Considering the potent antioxidant effects of SFN, we have a hypothesis that SFN would be a potential therapeutic drug for schizophrenia. The purpose of this study is to determine whether SFN-rich broccoli sprout extract have beneficial effects in patients with schizophrenia.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Schizophrenia for DSM-IV TR criteria
  • •Patients are treated with an antipsychotic drug (risperidone, olanzapine, quetiapine, perospirone, aripiprazole, blonanserin, paliperidone).
  • •Patients are stable for 4-weeks for antipsychotic medication.

排除标准

  • •Patients treated with clozapine
  • •Patients treated with two or more antipsychotic drugs
  • •Pregnant or breast-feeding women
  • •Patients treated with sulforaphane for more than 8-weeks in the past.

研究组 & 干预措施

A single-arm study

Experimental

干预措施: Sulforaphane-rich Broccoli Sprout Extract (Dietary Supplement)

结局指标

主要结局

Positive and Negative Syndrome Scale (PANSS)

时间窗: Change from baseline in PANSS scores at 8-weeks

次要结局

  • Cognition using CogState Research Battery(Change from baseline in the scores of the battery at 8-weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kenji Hashimoto

Sulforaphane for Schizophrenia

Chiba University

研究点 (1)

Loading locations...

相似试验